New Delhi: ENTOD Pharmaceuticals has appointed Balasubramanian K Pillai as its new Chief Financial Officer (CFO). With over 26 years of experience, Pillai brings deep expertise in financial planning, risk management, and business growth across multiple industries and global markets. In his new role, he will oversee financial strategy, budgeting, and risk management, helping ENTOD strengthen its financial position and drive long-term expansion.
Pillai has held leadership positions at Reliance Group, Globacom Africa, Petroleum Development of Oman, and Akums Group, working across India, MENA, Europe, and Africa in sectors like telecom, technology, education, pharmaceuticals, and manufacturing. His proven track record in managing financial operations, enhancing efficiency, and driving business success makes him a valuable addition to ENTOD’s leadership team.
Nikkhil K. Masurkar, CEO, ENTOD Pharmaceuticals, welcomed Pillai’s appointment, stating, “We are delighted to welcome Mr. Balasubramanian K Pillai as our new CFO. His experience in financial strategy and operational excellence will help ENTOD grow and expand globally. We look forward to his leadership in strengthening our financial operations and supporting our long-term vision.”
A Chartered Accountant, Pillai holds a First-Class Postgraduate Degree from the University of Pune, an LLB from the University of Mumbai, an SMP from IIM Calcutta, and is a Certified Information Systems Auditor (CISA) from ISACA, USA.
Expressing his enthusiasm, Balasubramanian K Pillai said, “I am excited to be part of ENTOD Pharmaceuticals at this important stage of its journey. I look forward to using my experience to improve financial strategies, increase efficiency, and contribute to the company’s success. Together with the team, I hope to drive sustainable growth and innovation.”
